Literature DB >> 23687080

6p21.3 microdeletion involving the SYNGAP1 gene in a patient with intellectual disability, seizures, and severe speech impairment.

Karin Writzl1, Alida C Knegt.   

Abstract

The chromosome 6p21.3 microdeletion phenotype was recently identified through array comparative genomic hybridization. The main features are developmental delay with severe speech impairment, seizures, and behavioral abnormalities. Three patients have been reported with deletion sizes ranging from 100 to 800 kb. We report on a 9-year-old boy with an apparently de novo, 50 kb deletion, and global developmental delay, severe speech impairment, and generalized epilepsy well-controlled by medication. There were four genes identified in this deletion, of which SYNGAP1 is considered to be responsible for speech impairment and epilepsy. We compared the clinical features of this patient with previously reported patients with 6p21.3 and patients with SYNGAP1 mutations. © 2013 Wiley Periodicals, Inc.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23687080     DOI: 10.1002/ajmg.a.35930

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  11 in total

1.  Syngap1 haploinsufficiency damages a postnatal critical period of pyramidal cell structural maturation linked to cortical circuit assembly.

Authors:  Massimiliano Aceti; Thomas K Creson; Thomas Vaissiere; Camilo Rojas; Wen-Chin Huang; Ya-Xian Wang; Ronald S Petralia; Damon T Page; Courtney A Miller; Gavin Rumbaugh
Journal:  Biol Psychiatry       Date:  2014-08-13       Impact factor: 13.382

2.  Comparison of Treadmill Gait Between a Pediatric-Aged Individual With SYNGAP1-Related Intellectual Disability and a Fraternal Twin.

Authors:  Charles S Layne; Christopher A Malaya; David R Young; Berhard Suter; Jimmy L Holder
Journal:  Front Hum Neurosci       Date:  2022-06-22       Impact factor: 3.473

3.  Clinical and behavioural features of SYNGAP1-related intellectual disability: a parent and caregiver description.

Authors:  Damien Wright; Aisling Kenny; Sarah Eley; Andrew G McKechanie; Andrew C Stanfield
Journal:  J Neurodev Disord       Date:  2022-06-02       Impact factor: 4.074

4.  Convergent synaptic and circuit substrates underlying autism genetic risks.

Authors:  Aaron McGee; Guohui Li; Zhongming Lu; Shenfeng Qiu
Journal:  Front Biol (Beijing)       Date:  2014-02-01

5.  Identification of an individual with a SYGNAP1 pathogenic mutation in India.

Authors:  Vijaya Verma; Amit Mandora; Abhijeet Botre; James P Clement
Journal:  Mol Biol Rep       Date:  2020-10-22       Impact factor: 2.316

Review 6.  Prioritizing the development of mouse models for childhood brain disorders.

Authors:  Kevin K Ogden; Emin D Ozkan; Gavin Rumbaugh
Journal:  Neuropharmacology       Date:  2015-07-29       Impact factor: 5.250

7.  De novo, heterozygous, loss-of-function mutations in SYNGAP1 cause a syndromic form of intellectual disability.

Authors:  Michael J Parker; Alan E Fryer; Deborah J Shears; Katherine L Lachlan; Shane A McKee; Alex C Magee; Shehla Mohammed; Pradeep C Vasudevan; Soo-Mi Park; Valérie Benoit; Damien Lederer; Isabelle Maystadt; Ddd Study; David R FitzPatrick
Journal:  Am J Med Genet A       Date:  2015-06-15       Impact factor: 2.802

Review 8.  SYNGAP1: Mind the Gap.

Authors:  Nallathambi Jeyabalan; James P Clement
Journal:  Front Cell Neurosci       Date:  2016-02-15       Impact factor: 5.505

9.  SynGAP isoforms differentially regulate synaptic plasticity and dendritic development.

Authors:  Yoichi Araki; Ingie Hong; Timothy R Gamache; Shaowen Ju; Leonardo Collado-Torres; Joo Heon Shin; Richard L Huganir
Journal:  Elife       Date:  2020-06-24       Impact factor: 8.140

Review 10.  Understanding intellectual disability and autism spectrum disorders from common mouse models: synapses to behaviour.

Authors:  Vijaya Verma; Abhik Paul; Anjali Amrapali Vishwanath; Bhupesh Vaidya; James P Clement
Journal:  Open Biol       Date:  2019-06-12       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.